In vitro, CXCL7 improves tumor stem cell properties, including tumorsphere formation capacity and migration ability; in vivo, CXCL7 increases the incidence and shortens the survival time of gliomas in mice (Yan et al., 2021). This evidence concerns the gene PPBP and central nervous system cancer.